The clinical significance of increased NGAL concentrations without detectable changes in creatinine, previously interpreted as a shortcoming of the biomarker, has been found to indicate sub-clinical AKI and to be of prognostic importance in critically ill adult patients [40]. Here, LCN2 is linked to acute kidney injury.